Tata India Pharma & Healthcare Fund Direct Growth
Tata India Pharma & Healthcare Fund Direct Growth

Tata India Pharma & Healthcare Fund Direct Growth

Compare
Equity
Direct
Sector - Healthcare

NAV: ₹ 19 as on 28-11-2022

Fund Performance
zero opening, trading, fund transfer fee
1175 people have invested ₹ 19.8L in mutual fund in the last three months

INDmoney Rank

Powered by IND quant engine
IND ranking is not available for this fund.
Pros
5Y returns in the top 25% of the category
Among most bought funds within the category
Beats FD returns for both 3Y & 5Y duration
Cons
3Y returns in the bottom 25% of the category

Fund Performance

Return
1M
3M
6M
1Y
3Y
5Y
This Fund
0.6%
5.9%
8.4%
-1.4%
23.6%
16.3%
Benchmark
3.6%
5.4%
13.8%
7.7%
17.2%
11.3%
Category
0.2%
4.4%
7.9%
-4.1%
23%
14.5%
About the Fund

Tata India Pharma & Healthcare Fund Direct Growth is an equity fund. This fund was started on  28 December, 2015. The fund is managed by Meeta Shetty. The fund could potentially beat inflation in the long-run.

Key parameters

1) Tata India Pharma & Healthcare Fund Direct Growth has a NAV of 19.0229 as on 28-11-2022.

2) Tata India Pharma & Healthcare Fund Direct Growth has 535 Cr worth of assets under management (AUM) as on 30-09-2022 and is less than category average.

3) The fund has an expense ratio 0.99 %.

Fund Overview

Expense ratio
Expense ratio
0.99%
Benchmark
Benchmark
S&P BSE Healthcare PR
AUM
AUM
₹535 Cr
Inception Date
Inception Date
28 December, 2015
Min Lumpsum/SIP
Min Lumpsum/SIP
₹5000/₹150
Exit Load
Exit Load
0.25%
Lock In
Lock In
No Lock-in
TurnOver
TurnOver
32.08%

Fund Distribution

  • Equity 98.5%
  • Debt & Cash 1.5%
Size breakup
Large cap
54.1%
Mid cap
26%
Small cap
18.4%

Sector Allocation

Oct'22

Sep'22

Aug'22

Health

99%

Financial Services

1%

Top Holdings

  • All
  • Equity
  • Debt & Cash
Total Holdings27
Equity Holdings25
Debt Holdings2

What changed

in last one month
  • Scheme
  • Portfolio
AUM increased by 15.8 Cr in last 1M
Oct'22 return underperformed benchmark

Change in AUM

Oct'22
₹ 535.4 Cr
Sep'22
₹ 519.7 Cr
Aug'22
₹ 519.1 Cr

Fund Returns vs Benchmark

Oct'22
2.81%
5.37%
Sep'22
2.49%
-2.51%
Aug'22
-0.19%
3.22%
Fund Return
Benchmark Return

Concentration Analysis

Fund
Oct'22
Oct'22
Aug'22
No of Holdings
27
27
28
Top 5 Company Concentration
52.7%
52.3%
53.1%
Company having highest exposure
Sun Pharmaceuticals Industries Ltd (17.3%)
Sun Pharmaceuticals Industries Ltd (16.7%)
Sun Pharmaceuticals Industries Ltd (15.7%)
No of Sectors
3
3
3
Top 5 Sectors Concentration
100%
100%
100%
Sector having highest exposure
Health (97.5%)
Health (94.7%)
Health (98%)

Fund Manager

Meeta Shetty

Meeta Shetty

Managing this fund since 9 March 2021

Top funds managed

Scheme
Annualised Returns(3Y)
Category Returns(3Y)
Tata Digital India Fund Direct Growth
33.36%
32.95%
Tata Large & Mid Cap Fund Direct Plan Growth
19.59%
18.25%
Tata Focused Equity Fund Direct Growth
0%
16.38%

AMC details

Address
Tata Asset Management Private Limited,Mafatlal Centre, 9th Floor,,Nariman Point,,India
Phone
+912266578282
Fund House
Tata Asset Management Limited

Fund Highlights

meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 9.74% since inception which is less than its category average return of 17.89%
Fund Allocations

Fund Allocations

This fund has an allocation of 98.46% in Equity, 0% in Debt and 1.54% in Cash related instruments
AUM size ₹535 Cr

AUM size ₹535 Cr

This fund has AUM of ₹535 Cr which is less than its category average of ₹ 1367 Cr
Expense Ratio 0.99%

Expense Ratio 0.99%

This fund has an expense ratio of 0.99% which is less than its category average expense ratio of 1.52%

Frequently Asked Questions

The current NAV of Tata India Pharma & Healthcare Fund Direct Growth is 19.
Existing (Absolute + CAGR)
Tata India Pharma & Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
0.76%
0.76%
6 Month Returns
9.09%
9.09%
1 Year Returns
-0.47%
-0.47%
3 Years Returns
90.74%
24.02%
5 Years Returns
111.56%
16.17%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
0.99 as on October 2022
535 Cr as on October 2022
Sun Pharmaceuticals Industries Ltd(17.32%),Cipla Ltd(13.19%),Dr Reddy's Laboratories Ltd(10.45%),Alkem Laboratories Ltd(6.07%),Apollo Hospitals Enterprise Ltd(5.64%) as on October 2022
Health(97.48%),Cash Equivalent(1.54%),Financial Services(0.98%) as on October 2022
The alpha ratio for the Tata India Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Tata India Pharma & Healthcare Fund Direct Growth
4.82
7.76
8.82
As on month end.
The alpha for Tata India Pharma & Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Tata India Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Tata India Pharma & Healthcare Fund Direct Growth
0.91
0.76
0.72
As on month end.
The Beta for Tata India Pharma & Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Tata India Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Tata India Pharma & Healthcare Fund Direct Growth
-0.15
1.07
0.67
As on month end.
The sharpe ratio for Tata India Pharma & Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Tata India Pharma & Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Tata India Pharma & Healthcare Fund Direct Growth
14
18.96
17.72
As on month end.
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
2.42
0.65
Meeta Shetty is the fund manager of Tata India Pharma & Healthcare Fund Direct Growth
The Exit load of Tata India Pharma & Healthcare Fund Direct Growth is 0.25%

Mutual Fund execution provided by

Technology facilitation Services provided by Finzoom Investment Advisors Pvt. Ltd. - Advisory unit. SEBI Registered Investment Advisor: INA100012190 | BASL Registration No. 1154 | BSE StarMF Platform code: 24801

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme related documents carefully. Past performance is not indicative of future returns.